Home » Topics » Regulatory » Patents

Patents
RSS

Takeda presents new histamine H3 receptor antagonists

Aug. 3, 2011

Sanofi discloses novel protein kinase inhibitors

Aug. 3, 2011

Bristol-Myers Squibb synthesizes novel HCV NS5A inhibitors

Aug. 2, 2011

New GLP-1 analogues and derivatives disclosed by Novo Nordisk

Aug. 2, 2011

Novel c-Akt inhibitors synthesized at ArQule

Aug. 2, 2011

Poxel discloses new AMPK activators

Aug. 2, 2011

Merck KGaA presents novel sphingosine kinase 1 inhibitors

Aug. 2, 2011

New histamine H3 receptor antagonists prepared at Takeda

Aug. 2, 2011

Scynexis synthesizes new agents for hepatitis C

Aug. 1, 2011

Novel metabotropic glutamate mGlu5 receptor agonists reported

Aug. 1, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...